[Preclinical trials of L-lysine-alpha-oxidase, an antitumor enzyme]

Antibiot Khimioter. 2010;55(9-10):33-6.
[Article in Russian]

Abstract

The effect of L-lysine-alpha-oxidase from a representative of the Trichoderma genus on the humoral immune response to protein antigens was studied. It was shown that repeated fife-fold intravenous administrations of L-lysine-alpha-oxidase in a dose of 35 U/kg had no depressive action on the humoral immunity. The enzyme had no suppressive effect on the delayed type hypersensitivity to xenogenous erythrocytes. The use of L-lysine-alpha-oxidase in a therapeutic dose or in a twice as higher dose had no reliable effect on the leukocyte migration capacity vs. the control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Oxidoreductases / pharmacology*
  • Animals
  • Antibodies / blood
  • Antibodies / immunology
  • Antibody Formation / drug effects*
  • Antineoplastic Agents / pharmacology*
  • Asparaginase / immunology
  • Cell Movement / immunology
  • Drug Evaluation, Preclinical
  • Erythrocytes / immunology
  • Escherichia coli / enzymology
  • Immunity, Humoral / immunology*
  • Immunization
  • Leukocytes / physiology
  • Mice
  • Mice, Inbred CBA
  • Ovalbumin / immunology
  • Sheep
  • Trichoderma / enzymology*

Substances

  • Antibodies
  • Antineoplastic Agents
  • Ovalbumin
  • Amino Acid Oxidoreductases
  • L-lysine oxidase
  • Asparaginase